Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

VTAK vs IPST: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

IPST Wins Head-to-Head Institutional Verdict (3–1 across 6 Pillars · 4–4 Matrix Metrics)

IPST Overall Winner 6-Pillar Tally: VTAK 1 – 3 IPST (2 Tie) Matrix Metrics: VTAK 4 – 4 IPST

As of Nov 16, 2026, Heritage Distilling Holding Company, Inc. (IPST) is the stronger overall head-to-head candidate over Catheter Precision, Inc. (VTAK) in the Tradestie Institutional Equity Comparison Engine, winning 4–4 core matrix metrics and 3–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). VTAK carries a Unified Composite Score of 58.1/100 (HOLD) at $0.15 (N/M Forward P/E, -388.1% operating margin), whereas IPST carries 47.0/100 (HOLD) at $1.93 (0.4x Forward P/E, -83.5% operating margin).

  • Composite vs. Pillar Nuance: While VTAK currently prints a higher short-term Unified Composite Score (58.1/100 HOLD vs. IPST 47.0/100 HOLD), IPST captures the overall institutional head-to-head verdict (4–4 matrix metrics and 3–1 across the 6 pillars) due to superior fundamental profitability (-83.5% vs. -388.1% operating margin) and revenue trajectory (-42.8% vs. +380.7% YoY).
  • Technical & Structure Timing Caution: VTAK is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.2); meanwhile IPST is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About VTAK vs IPST
VTAK NYSE American
Catheter Precision, Inc.
Surgical & Medical Instruments & Apparatus
$0.15
-0.66% 1D
Market Cap $548,639
TTM Revenue $1.9M
Forward P/E N/M
Beta / 30D Vol 0.19β · 76% Vol
Unified Composite Score
58.1 / 100 HOLD
Tech 72.0 Fund 70.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -53.4%), weak momentum, RSI 33
RSI-14: 33.2 · SMA20: $0.16 · SMA50: $0.21
IPST NASDAQ Head-to-Head Winner
Heritage Distilling Holding Company, Inc. Common Stock
Beverages
$1.93
-5.85% 1D
Market Cap $1.5M
TTM Revenue $10.0M
Forward P/E 0.4x
Beta / 30D Vol -5.30β · 142% Vol
Unified Composite Score
47.0 / 100 HOLD
Tech 40.0 Fund 52.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -32.6%), weak momentum, RSI 39
RSI-14: 38.6 · SMA20: $2.32 · SMA50: $2.76

6-Pillar Scorecard Institutional Category Breakdown (VTAK 1 – 3 IPST)

Columns: Metric · VTAK · IPST
1. Valuation Multiples IPST
Forward P/E N/M 0.4x
Trailing P/E N/M 1.2x
PEG Ratio N/M N/M
EV / Revenue 0.3x 0.6x
2. Growth & Scale VTAK
Revenue Growth (YoY) +380.7% -42.8%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $1.9M $10.0M
Market Cap $548,639 $1.5M
3. Profitability & Quality IPST
Gross Margin 47.7% 66.5%
Operating Margin -388.1% -83.5%
Net Profit Margin 0.0% 0.0%
Return on Equity (ROE) -111.3% -2713.2%
4. Balance Sheet & Cash Flow IPST
Cash Generation (TTM) -$10M EBITDA -$7.8M EBITDA
Cash Flow Margin N/A -77.9% EBITDA Mgn
Net Cash / Leverage $4.87 Book/Sh · -111.3% ROE $4.5M Net Debt (0.14x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Devices Operator Capital Markets Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: VTAK (4) vs IPST (4)
Institutional Metric VTAK IPST Criterion Row Edge
Market Capitalization
Scale
$548,639 $1.5M Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M 1.2x Lower Multiple IPST
Forward P/E Ratio
Valuation
N/M 0.4x Lower Multiple IPST
Revenue Growth (YoY)
Growth
+380.7% -42.8% Higher Growth VTAK
Operating Margin (TTM)
Profitability
-388.1% -83.5% Higher Margin IPST
Net Profit Margin
Profitability
0.0% 0.0% Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
-111.3% -2713.2% Higher ROE VTAK
52-Week Range Position
Momentum
1% ($0–$3) 7% ($0–$25) Stronger Trend IPST
Beta / 30D Volatility
Risk Regime
0.19β · 76% Vol -5.30β · 142% Vol Lower Realized Risk VTAK
Unified Institutional Score
Composite Signal
58.1 / 100 (HOLD) 47.0 / 100 (HOLD) Higher Composite VTAK
Trailing 12M Revenue (USD)
Operating Scale
$1.9M $10.0M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
47.7% 66.5% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.3x EV/Rev N/M PEG · 0.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$10M EBITDA ($4.87 Book/Sh · -111.3% ROE) -$7.8M EBITDA ($4.5M Net Debt (0.14x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon VTAK +0.48 pp
VTAK: -24.76% · IPST: -25.24%
3M Horizon IPST +99.21 pp
VTAK: -80.29% · IPST: +18.92%
6M Horizon IPST +1246.06 pp
VTAK: -83.76% · IPST: +1162.3%
1Y Horizon IPST +13.41 pp
VTAK: -92.63% · IPST: -79.22%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period VTAK Revenue IPST Revenue VTAK Op. Margin IPST Op. Margin Margin Leader
FY2018 $10M N/A -498.0% N/A VTAK
FY2019 $10M N/A -801.9% N/A VTAK
FY2020 $0M N/A -13668.3% N/A VTAK
FY2021 $0M N/A -133027.3% N/A VTAK
FY2022 $0M N/A -192578.6% N/A VTAK
FY2023 $0M $10M -17674.0% -141.3% IPST
FY2024 $0M $10M -2676.9% -177.6% IPST
FY2025 $0M $10M -2581.6% -1323.6% IPST

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
VTAK UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact VTAK Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
IPST UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact IPST Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
VTAK Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $548,639 market capitalization and -388.1% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
IPST Moat Profile Cyclical / Execution-Driven Positioning
Capital Markets Operator
Competes within the Capital Markets value chain with $1.5M market capitalization and -83.5% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ VTAK vs IPST Key Questions & Quantitative Answers

As of Nov 16, 2026, Heritage Distilling Holding Company, Inc. (IPST) is the stronger overall head-to-head candidate over Catheter Precision, Inc. (VTAK) in the Tradestie Institutional Equity Comparison Engine, winning 4–4 core matrix metrics and 3–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). VTAK carries a Unified Composite Score of 58.1/100 (HOLD) at $0.15 (N/M Forward P/E, -388.1% operating margin), whereas IPST carries 47.0/100 (HOLD) at $1.93 (0.4x Forward P/E, -83.5% operating margin). Composite vs. Pillar Nuance: While VTAK currently prints a higher short-term Unified Composite Score (58.1/100 HOLD vs. IPST 47.0/100 HOLD), IPST captures the overall institutional head-to-head verdict (4–4 matrix metrics and 3–1 across the 6 pillars) due to superior fundamental profitability (-83.5% vs. -388.1% operating margin) and revenue trajectory (-42.8% vs. +380.7% YoY). Technical & Structure Timing Caution: VTAK is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.2); meanwhile IPST is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

VTAK leads the Growth & Scale pillar: VTAK posts +380.7% YoY revenue growth and +0.0% YoY earnings growth on $1.9M TTM revenue (47.7% gross margin, -388.1% operating margin), compared with IPST at -42.8% YoY revenue growth and +0.0% YoY earnings growth on $10.0M TTM revenue (66.5% gross margin, -83.5% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), VTAK cumulative revenue shifted +0.0% while IPST shifted +0.0%. In operating R&D and SG&A reinvestment, VTAK deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for IPST.

IPST screens cheaper on headline valuation multiples. VTAK trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.3x EV/Revenue (unreported EBITDA margin), whereas IPST trades at 0.4x Forward P/E, 1.2x Trailing P/E, N/M PEG, and 0.6x EV/Revenue (-77.9% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against VTAK (-111.3% ROE) versus IPST (-2713.2% ROE) capital efficiency.

In options market volatility and institutional positioning, VTAK carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.19β · 76% Vol realized risk). By comparison, IPST carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-5.30β · 142% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.